|
1150 Elijah McCoy Dr. Detroit, MI 48202 MI Tel. 313-871-8400 Fax 313-871-8314 |
Type: Public
On the web:
http://www.caraco.com
Employees:
535
Employee growth: (19.8%)
Caraco Pharmaceutical Laboratories peddles cheaper versions of prescription drugs. The drug company sells generic knock-offs of a wide variety of pharmaceuticals, including about 40 prescription products in various strengths and dosages. Its product lineup includes treatments for high blood pressure, cancer, nervous system conditions, diabetes, allergies, and pain. Indian drugmaker Sun Pharmaceutical Industries owns a majority stake in the firm and licenses US marketing rights to Caraco for a number of generic drugs. Caraco markets its products throughout the US and Puerto Rico, selling primarily to pharmaceutical wholesalers. However, it has halted manufacturing operations due to regulatory concerns.
Key numbers for fiscal year ending March, 2010:
Sales: $233.7M
One year growth: (30.7%)
Net income: ($8.7)M
Officers:
Chairman: Dilip S. Shanghvi
CEO and Director: Gurpartap Singh Sachdeva
Interim CFO: Mukul Rathi
Competitors:
Mylan
Teva Pharmaceuticals USA
Watson Pharmaceuticals
CPD can refer to any of the following:
| This disambiguation page lists articles associated with the same title. If an internal link led you here, you may wish to change the link to point directly to the intended article. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)